HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Short term therapy for uncomplicated urinary tract infection today. Clinical outcome upholds the theories.

Abstract
The clinical and bacteriological activity of fosfomycin trometamol (FT) has been compared with several other antibiotics in the treatment of uncomplicated urinary tract infections. A single dose of FT had activity comparable with a 5-day course of trimethoprim in a trial where the causative organism and its sensitivity were unknown. In another trial FT showed better long term eradication compared with a 5-day course of cephalexin and other studies suggested a single dose of FT was comparable with a 7-day course of nitrofurantoin or norfloxacin. There were few important side effects with fosfomycin therapy and it was considered a safe and effective first line treatment in uncomplicated urinary tract infection.
AuthorsB Lobel
JournalInternational journal of antimicrobial agents (Int J Antimicrob Agents) Vol. 22 Suppl 2 Pg. 85-7 (Oct 2003) ISSN: 0924-8579 [Print] Netherlands
PMID14527777 (Publication Type: Comparative Study, Journal Article, Review)
Chemical References
  • Anti-Bacterial Agents
  • Fosfomycin
  • Nitrofurantoin
  • Trimethoprim
  • Norfloxacin
  • Cephalexin
Topics
  • Anti-Bacterial Agents (administration & dosage, therapeutic use)
  • Bacterial Infections (drug therapy)
  • Cephalexin (therapeutic use)
  • Clinical Trials as Topic
  • Dose-Response Relationship, Drug
  • Female
  • Fosfomycin (administration & dosage, therapeutic use)
  • Humans
  • Longitudinal Studies
  • Meta-Analysis as Topic
  • Nitrofurantoin (administration & dosage, therapeutic use)
  • Norfloxacin (therapeutic use)
  • Treatment Outcome
  • Trimethoprim (therapeutic use)
  • Urinary Tract Infections (drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: